Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection
Clinical trial NCT04147208 · COMPLETED
Trial details
- NCT number
- NCT04147208
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2022-06-23
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.